20152019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ardi Pambuku is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

  • Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor

    Ceccato, F., Lombardi, G., Albiger, N., Mazzai, L., Pambuku, A., Rolma, G., Zagonel, V. & Scaroni, C., Jun 2019, In : Anti-Cancer Drugs. 30, 5, p. 533-536 4 p.

    Research output: Contribution to journalArticle

  • Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma

    Indraccolo, S., Lombardi, G., Fassan, M., Pasqualini, L., Giunco, S., Marcato, R., Gasparini, A., Candiotto, C., Nalio, S., Fiduccia, P., Fanelli, G. N., Pambuku, A., Della Puppa, A., D'Avella, D., Bonaldi, L., Gardiman, M. P., Bertorelle, R., De Rossi, A. & Zagonel, V., Dec 4 2018, In : Clinical Cancer Research.

    Research output: Contribution to journalArticle

  • Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases

    Lombardi, G., Caccese, M., Bellu, L., Pambuku, A., Bergo, E., Berti, F., Gardiman, M. P., Della Puppa, A., Denaro, L., Dal Pos, S. & Zagonel, V., Oct 2018, In : Anti-Cancer Drugs. 29, 9, p. 924-928 5 p.

    Research output: Contribution to journalArticle